Cargando…
Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?
BACKGROUND: Salvage treatments for recurrent NSCLC after first‐line chemotherapy remain challenging. This study was conducted to evaluate the clinical value of microwave ablation (MWA) and iodine‐125 brachytherapy, including overall survival (OS), disease free survival (DFS), local control, hospital...
Autores principales: | Liu, Bin, Wang, Yongzheng, Tian, Shilin, Hertzanu, Yancu, Zhao, Xiaogang, Li, Yuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049489/ https://www.ncbi.nlm.nih.gov/pubmed/31995853 http://dx.doi.org/10.1111/1759-7714.13320 |
Ejemplares similares
-
CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors
por: Cao, Qianqian, et al.
Publicado: (2014) -
CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
por: Dong, Hong, et al.
Publicado: (2021) -
Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018) -
(125)I Brachytherapy Seeds Implantation for Inoperable Low-Grade Leiomyosarcoma of Inferior Vena Cava
por: Li, Yuliang, et al.
Publicado: (2013) -
CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023)